- 24 October 2017Portfolio NewsDDF notes major collaboration between portfolio company Alector and AbbVie
- 6 July 2017Portfolio NewsDDF Invests in $20 Million in Series A Funding of Mitoconix Bio to Develop Neurodegenerative Disease Therapies
- 21 June 2017Portfolio NewsAdimab Provides Mid-Year Update on 2017 Partnership Activity
- 19 June 2017SV NewsDementia Discovery Fund Annual Update
- 1 June 2017Portfolio NewsBicycle Therapeutics Closes £40 Million ($52 Million) in Series B Financing to Advance Clinical Pipeline
- 3 May 2017Portfolio NewsDDF to Invest $5 Million in Cerevance to Seek New Treatments for Dementia
- 1 May 2017Portfolio NewsAligned Telehealth Names Dan Castillo President and COO
- 27 April 2017Portfolio NewsArsanis Completes $45.5 Million Series D Financing
- 11 April 2017SV NewsSV Health Investors Closes on New Fund Focused on Creating and Growing Companies That Advance Science and Transform Healthcare
- 10 April 2017SV NewsSV Life Sciences Changes Name to SV Health Investors to Better Reflect the Firm's Longstanding Strategy and Focus
- 15 March 2017Portfolio NewsAutifony Therapeutics obtains £1.3 million in funding from Innovate UK and the Dementia Discovery Fund to explore novel approach to treatment of dementia
- 28 February 2017SV NewsDDF Acquires Small Molecule Library and Enters Strategic Partnership with Aptuit to Kickstart Dementia Drug Discovery Programmes